<section xmlns="http://xml.house.gov/schemas/uslm/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" style="-uslm-lc:I80" id="ida4a8b82c-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l"><num value="284l">§ 284l.</num><heading> Enhancement awards</heading><subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4a8b82d-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/a"><num value="a" class="bold">(a)</num><heading class="bold"> Mentored Patient-Oriented Research Career Development Awards</heading><paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a8b82e-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/a/1"><num value="1" class="bold">(1)</num><heading class="bold"> Grants</heading><subparagraph style="-uslm-lc:I18" class="indent4 firstIndent-2" id="ida4a8b82f-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/a/1/A"><num value="A" class="bold">(A)</num><heading class="bold"> In general</heading><content><p style="-uslm-lc:I13" class="indent2">The Director of the National Institutes of Health shall make grants (to be referred to as “Mentored Patient-Oriented Research Career Development Awards”) to support individual careers in clinical research at general clinical research centers or at other institutions that have the infrastructure and resources deemed appropriate for conducting patient-oriented clinical research.</p>
</content>
</subparagraph>
<subparagraph style="-uslm-lc:I18" class="indent4 firstIndent-2" id="ida4a8df40-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/a/1/B"><num value="B" class="bold">(B)</num><heading class="bold"> Use</heading><content><p style="-uslm-lc:I13" class="indent2">Grants under subparagraph (A) shall be used to support clinical investigators in the early phases of their independent careers by providing salary and such other support for a period of supervised study.</p>
</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a8df41-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/a/2"><num value="2" class="bold">(2)</num><heading class="bold"> Applications</heading><content><p style="-uslm-lc:I12" class="indent1">An application for a grant under this subsection shall be submitted by an individual scientist at such time as the Director may require.</p>
</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4a8df42-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/b"><num value="b" class="bold">(b)</num><heading class="bold"> Mid-Career Investigator Awards in Patient-Oriented Research</heading><paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a8df43-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/b/1"><num value="1" class="bold">(1)</num><heading class="bold"> Grants</heading><subparagraph style="-uslm-lc:I18" class="indent4 firstIndent-2" id="ida4a8df44-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/b/1/A"><num value="A" class="bold">(A)</num><heading class="bold"> In general</heading><content><p style="-uslm-lc:I13" class="indent2">The Director of the National Institutes of Health shall make grants (to be referred to as “Mid-Career Investigator Awards in Patient-Oriented Research”) to support individual clinical research projects at general clinical research centers or at other institutions that have the infrastructure and resources deemed appropriate for conducting patient-oriented clinical research.</p>
</content>
</subparagraph>
<subparagraph style="-uslm-lc:I18" class="indent4 firstIndent-2" id="ida4a8df45-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/b/1/B"><num value="B" class="bold">(B)</num><heading class="bold"> Use</heading><content><p style="-uslm-lc:I13" class="indent2">Grants under subparagraph (A) shall be used to provide support for mid-career level clinicians to allow such clinicians to devote time to clinical research and to act as mentors for beginning clinical investigators.</p>
</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a8df46-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/b/2"><num value="2" class="bold">(2)</num><heading class="bold"> Applications</heading><content><p style="-uslm-lc:I12" class="indent1">An application for a grant under this subsection shall be submitted by an individual scientist at such time as the Director requires.</p>
</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4a8df47-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c"><num value="c" class="bold">(c)</num><heading class="bold"> Graduate Training in Clinical Investigation Award</heading><paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a8df48-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/1"><num value="1" class="bold">(1)</num><heading class="bold"> In general</heading><content><p style="-uslm-lc:I12" class="indent1">The Director of the National Institutes of Health shall make grants (to be referred to as “Graduate Training in Clinical Investigation Awards”) to support individuals pursuing master’s or doctoral degrees in clinical investigation.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a8df49-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/2"><num value="2" class="bold">(2)</num><heading class="bold"> Applications</heading><content><p style="-uslm-lc:I12" class="indent1">An application for a grant under this subsection shall be submitted by an individual scientist at such time as the Director may require.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a8df4a-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/3"><num value="3" class="bold">(3)</num><heading class="bold"> Limitations</heading><content><p style="-uslm-lc:I12" class="indent1">Grants under this subsection shall be for terms of 2 years or more and shall provide stipend, tuition, and institutional support for individual advanced degree programs in clinical investigation.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a8df4b-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/4"><num value="4" class="bold">(4)</num><heading class="bold"> Definition</heading><chapeau style="-uslm-lc:I12" class="indent1">As used in this subsection, the term “advanced degree programs in clinical investigation” means programs that award a master’s or Ph.D. degree in clinical investigation after 2 or more years of training in areas such as the following:</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a8df4c-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/4/A"><num value="A">(A)</num><content> Analytical methods, biostatistics, and study design.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a8df4d-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/4/B"><num value="B">(B)</num><content> Principles of clinical pharmacology and pharmacokinetics.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a8df4e-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/4/C"><num value="C">(C)</num><content> Clinical epidemiology.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a8df4f-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/4/D"><num value="D">(D)</num><content> Computer data management and medical informatics.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a8df50-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/4/E"><num value="E">(E)</num><content> Ethical and regulatory issues.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a8df51-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/c/4/F"><num value="F">(F)</num><content> Biomedical writing.</content>
</subparagraph>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="ida4a8df52-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d"><num value="d" class="bold">(d)</num><heading class="bold"> Clinical Research Curriculum Awards</heading><paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a8df53-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d/1"><num value="1" class="bold">(1)</num><heading class="bold"> In general</heading><chapeau style="-uslm-lc:I12" class="indent1">The Director of the National Institutes of Health shall make grants (to be referred to as “Clinical Research Curriculum Awards”) to institutions for the development and support of programs of core curricula for training clinical investigators, including medical students. Such core curricula may include training in areas such as the following:</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a8df54-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d/1/A"><num value="A">(A)</num><content> Analytical methods, biostatistics, and study design.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a90665-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d/1/B"><num value="B">(B)</num><content> Principles of clinical pharmacology and pharmacokinetics.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a90666-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d/1/C"><num value="C">(C)</num><content> Clinical epidemiology.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a90667-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d/1/D"><num value="D">(D)</num><content> Computer data management and medical informatics.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a90668-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d/1/E"><num value="E">(E)</num><content> Ethical and regulatory issues.</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="ida4a90669-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d/1/F"><num value="F">(F)</num><content> Biomedical writing.</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a9066a-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d/2"><num value="2" class="bold">(2)</num><heading class="bold"> Applications</heading><content><p style="-uslm-lc:I12" class="indent1">An application for a grant under this subsection shall be submitted by an individual institution or a consortium of institutions at such time as the Director may require. An institution may submit only one such application.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="ida4a9066b-09a0-11eb-a85b-f5cef3d06f4d" identifier="/us/usc/t42/s284l/d/3"><num value="3" class="bold">(3)</num><heading class="bold"> Limitations</heading><content><p style="-uslm-lc:I12" class="indent1">Grants under this subsection shall be for terms of up to 5 years and may be renewable.</p>
</content>
</paragraph>
</subsection>
<sourceCredit id="ida4a9066c-09a0-11eb-a85b-f5cef3d06f4d">(<ref href="/us/act/1944-07-01/ch373">July 1, 1944, ch. 373</ref>, title IV, § 409H, formerly § 409D, as added <ref href="/us/pl/106/505/tII/s204/b">Pub. L. 106–505, title II, § 204(b)</ref>, <date date="2000-11-13">Nov. 13, 2000</date>, <ref href="/us/stat/114/2327">114 Stat. 2327</ref>; renumbered § 409H, <ref href="/us/pl/107/109/s3/2">Pub. L. 107–109, § 3(2)</ref>, <date date="2002-01-04">Jan. 4, 2002</date>, <ref href="/us/stat/115/1408">115 Stat. 1408</ref>; <ref href="/us/pl/109/482/tI/s103/b/13">Pub. L. 109–482, title I, § 103(b)(13)</ref>, <date date="2007-01-15">Jan. 15, 2007</date>, <ref href="/us/stat/120/3687">120 Stat. 3687</ref>.)</sourceCredit>
<notes type="uscNote" id="ida4a9066d-09a0-11eb-a85b-f5cef3d06f4d">
<note style="-uslm-lc:I74" topic="amendments" id="ida4a9066e-09a0-11eb-a85b-f5cef3d06f4d"><heading class="centered smallCaps">Amendments</heading><p style="-uslm-lc:I21" class="indent0">2007—Subsec. (a)(3). <ref href="/us/pl/109/482/s103/b/13/A">Pub. L. 109–482, § 103(b)(13)(A)</ref>, struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (b)(3). <ref href="/us/pl/109/482/s103/b/13/B">Pub. L. 109–482, § 103(b)(13)(B)</ref>, struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (c)(5). <ref href="/us/pl/109/482/s103/b/13/C">Pub. L. 109–482, § 103(b)(13)(C)</ref>, struck out heading and text of par. (5). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”</p>
<p style="-uslm-lc:I21" class="indent0">Subsec. (d)(4). <ref href="/us/pl/109/482/s103/b/13/D">Pub. L. 109–482, § 103(b)(13)(D)</ref>, struck out heading and text of par. (4). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”</p>
</note>
<note style="-uslm-lc:I74" topic="effectiveDateOfAmendment" id="ida4a9066f-09a0-11eb-a85b-f5cef3d06f4d"><heading class="centered smallCaps">Effective Date of 2007 Amendment</heading><p style="-uslm-lc:I21" class="indent0">Amendment by <ref href="/us/pl/109/482">Pub. L. 109–482</ref> applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see <ref href="/us/pl/109/482/s109">section 109 of Pub. L. 109–482</ref>, set out as a note under <ref href="/us/usc/t42/s281">section 281 of this title</ref>.</p>
</note>
</notes>
</section>